Preparation of 99mTc-PQQ and preliminary biological evaluation for the NMDA receptor
- PMID: 26224906
- PMCID: PMC4514009
- DOI: 10.1007/s10967-010-0845-5
Preparation of 99mTc-PQQ and preliminary biological evaluation for the NMDA receptor
Abstract
Pyrroloquinoline quinone (PQQ), an essential nutrient, antioxidant, redox modulator and nerve growth factor found in a class of enzymes called quinoproteins, was labeled with 99mTc by using stannous fluoride (SnF2) method. Radiolabeling qualification, quality control and characterization of 99mTc-PQQ and its biodistribution studies in mice were performed and discussed. Effects of pH values, temperature, time and reducing agents concentration on the radiolabeling yield were investigated. The quality control procedure of 99mTc-PQQ was determined by thin layer chromatography (TLC), radio high-performance liquid chromatography (RHPLC) and paper electrophoresis methods. The average radiolabeling yield was 94 ± 1% under optimum conditions of 0.99 mg of PQQ, 30 μg of SnF2, 0.5 mg of ethylenediaminetetraacetic acid disodium salt (EDTA-2Na) and 18.5 MBq of Na99mTcO4 at pH 6 and 25 °C with a response volume of 1 ± 0.1 mL. 99mTc-PQQ was stable and anionic. Lipid-water partition coefficient of 99mTc-PQQ was -1.49 ± 0.16. The pharmacokinetics parameters of 99mTc-PQQ were t1/2α = 18.16 min, t1/2β = 100.45 min, K12 = 0.013 min-1, K21 = 0.017 min-1, Ke = 0.016 min-1, AUC (area under the curve) = 1040.78 ID% g-1 min and CL (plasma clearance) = 0.096 mL min-1. The dual-exponential equation was Y = 10.88e-0.038t + 5.21e-0.0069t . The biodistribution of 99mTc-PQQ was studied in ICR (Institute for Cancer Research 7701 Burhelme Are., Fox Chase, Philadelphia, PA 1911 USA) mice. In vitro autoradiographic studies clearly showed that the 99mTc-PQQ radioactivity accumulated predominantly in the hippocampus and cortex, which had a high density of N-methyl-d-aspartate Receptor (NMDAR). The enrichment can be blocked by NMDAR redox modulatory site antagonists-ebselen (EB) and 99mTc-PQQ is therefore a promising candidate for the molecular imaging of NMDAR. To date, however, there have been no studies characterizing 99mTc-PQQ.
Keywords: 99mTc; 99mTc-PQQ; NMDAR; Pyrroloquinoline quinone.
Figures






Similar articles
-
Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.Nucl Med Commun. 2014 Apr;35(4):423-32. doi: 10.1097/MNM.0000000000000065. Nucl Med Commun. 2014. PMID: 24335877
-
[Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse].Zhongguo Fei Ai Za Zhi. 2015 Jul;18(7):422-6. doi: 10.3779/j.issn.1009-3419.2015.07.06. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26182867 Free PMC article. Chinese.
-
Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures.J Neurosci. 2000 Mar 15;20(6):2409-17. doi: 10.1523/JNEUROSCI.20-06-02409.2000. J Neurosci. 2000. PMID: 10704515 Free PMC article.
-
Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site.J Neurosci. 1992 Jun;12(6):2362-9. doi: 10.1523/JNEUROSCI.12-06-02362.1992. J Neurosci. 1992. PMID: 1318959 Free PMC article.
-
Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice.Behav Brain Res. 2014 Jan 1;258:153-9. doi: 10.1016/j.bbr.2013.10.025. Epub 2013 Oct 20. Behav Brain Res. 2014. PMID: 24149067
Cited by
-
Pyrroloquinoline Quinone Preconditioning Alleviates Ischemic Cerebral Injury Through Antioxidant and Anti-Inflammatory Mechanisms.J Neuroimmune Pharmacol. 2025 Jul 23;20(1):75. doi: 10.1007/s11481-025-10234-1. J Neuroimmune Pharmacol. 2025. PMID: 40696055
References
-
- Rucker R, Chowanadisai W, Nakano M. Altern Med Rev. 2009;14:268. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous